$2.77
-0.00010.00%
Last update: 9:09 AM
15 minutes delayed
Heron Therapeutics
HRTXNASDAQ
Heron Therapeutics (HRTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestHeron Therapeutics (NASDAQ:HRTX) Stock Quotes, Forecast and News Summary
Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.
| Open | $2.77 |
| Close | - |
| Volume / Avg. | 859.85K / 2.32M |
| Day Range | 2.70 - 2.85 |
| 52 Wk Range | 0.50 - 3.93 |
| Market Cap | $417.29M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 26.2% |
| Days to Cover | 20.38 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Heron Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the l...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Heron Therapeutics (HRTX) stock?
You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.
Who are Heron Therapeutics (HRTX) competitors?
Other companies in Heron Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO) and Altimmune (NASDAQ:ALT).
What is the target price for Heron Therapeutics (HRTX) stock?
There is no analysis for Heron Therapeutics.
What is the forecast for Heron Therapeutics (HRTX) stock?
Heron Therapeutics has a consensus price target of $7.00.
Current stock price for Heron Therapeutics (HRTX)?
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $2.775 last updated Today at July 5, 2024 at 1:02 PM EDT.
Does Heron Therapeutics (HRTX) pay a dividend?
There are no upcoming dividends for Heron Therapeutics.
When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?
Heron Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
Is Heron Therapeutics (HRTX) going to split?
There is no upcoming split for Heron Therapeutics.
What sector and industry does Heron Therapeutics (HRTX) operate in?
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.